Fosrenol Launches In UK Today - New Option To Control Phosphate Levels And Lower Pill Burden For Patients With Kidney Disease And Dialysis

... Today Shire plc announced the launch of FOSRENOL® (lanthanum carbonate) in the United Kingdom following the product's authorisation as a phosphate binding agent for use in the control of hyperphosphataemia in chronic renal failure patients on haemodialysis or continuous ambulatory peritoneal dialysis (CAPD). [click link for full article] ...